Related references
Note: Only part of the references are listed.Zolpidem for insomnia
David J. Greenblatt et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
A Method to Assess the Dissipation of the Effects of Residual Hypnotics Eszopiclone Versus Zopiclone
Julia Boyle et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Gender Differences in Highway Driving Performance After Administration of Sleep Medication: A Review of the Literature
Joris C. Verster et al.
TRAFFIC INJURY PREVENTION (2012)
Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity
Siamak Cyrus Khojasteh et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2011)
Eszopiclone for the Treatment of Posttraumatic Stress Disorder and Associated Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
Mark H. Pollack et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Psychomotor Performance After Intake of Zopiclone Compared With Intake of Ethanol A Randomized, Controlled, Double-Blinded Trial
Ingebjorg Gustavsen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Psychotropic Drug Prescribing in the United States Extent, Costs, and Expenditures
David J. Greenblatt et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects
Marie-Laure Bocca et al.
PSYCHOPHARMACOLOGY (2011)
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype
Johannes G. Ramaekers et al.
PSYCHOPHARMACOLOGY (2011)
Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects
Monique A. J. Mets et al.
SLEEP (2011)
Zopiclone as Positive Control in Studies Examining the Residual Effects of Hypnotic Drugs on Driving Ability
Joris C. Verster et al.
CURRENT DRUG SAFETY (2011)
Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial
Hadine Joffe et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
The strategy of enantiomer patents of drugs
Israel Agranat et al.
DRUG DISCOVERY TODAY (2010)
Stability tests of zopiclone in whole blood
Gunnel H. Nilsson et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics
David J. Nutt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology
David J. Nutt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Treatment of Insomnia in Parkinson's Disease: A Controlled Trial of Eszopiclone and Placebo
Matthew Menza et al.
MOVEMENT DISORDERS (2010)
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effect of Eszopiclone 2 mg on Sleep/Wake Function in Older Adults with Primary and Comorbid Insomnia
Sonia Ancoli-Israel et al.
SLEEP (2010)
Effect of hypnotic drugs on body balance and standing steadiness
Monique A. J. Mets et al.
SLEEP MEDICINE REVIEWS (2010)
The role of eszopiclone in the treatment of insomnia
Anna K. Morin et al.
ADVANCES IN THERAPY (2009)
In Vivo Saturation Binding of GABA-A Receptor Ligands to Estimate Receptor Occupancy Using Liquid Chromatography/Tandem Mass Spectrometry
Seth C. Hopkins et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Comparative Tolerability of Newer Agents for Insomnia
Gary Zammit
DRUG SAFETY (2009)
Highway Driving in the Elderly the Morning After Bedtime Use of Hypnotics A Comparison Between Temazepam 20 mg, Zopiclone 7.5 mg, and Placebo
Tim R. M. Leufkens et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem
Tim R. M. Leufkens et al.
JOURNAL OF SLEEP RESEARCH (2009)
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder
Mark Pollack et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States
Chris P. Miller et al.
CHIRALITY (2008)
Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone
Julia Boyle et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma
Hiren N. Mistri et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Facile synthesis of oleanolic acid monoglycosides and diglycosides
Yu Sha et al.
MOLECULES (2008)
Nightly treatment of primary insomnia with eszopiclone for six months: Effect on sleep, quality of life, and work limitations
James K. Walsh et al.
SLEEP (2007)
A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome
Russell Rosenberg et al.
SLEEP MEDICINE (2007)
Eszopiclone in patients with insomnia during perimenopause and early postmenopause - A randomized controlled trial
Claudio N. Soares et al.
OBSTETRICS AND GYNECOLOGY (2006)
Dynamics and kinetics of a modified-release formulation of zolpidem: Comparison with immediate-release standard zolpidem and placebo
David J. Greenblatt et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A polysomnography study of eszopiclone in elderly patients with insomnia
W. Vaughn McCall et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone
Aleksi Tornio et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Efficacy and safety of zolpidem-MR: A double-blind, placebo-controlled study in adults with primary insomnia
Thomas Roth et al.
SLEEP MEDICINE (2006)
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
M Fava et al.
BIOLOGICAL PSYCHIATRY (2006)
Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia
Jadwiga Najib
CLINICAL THERAPEUTICS (2006)
Eszopidone for the treatment of insomnia
M Scharf
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Hypnotics and Driving Safety: Meta-Analyses of Randomized Controlled Trials Applying the on-the-Road Driving Test
Joris C. Verster et al.
CURRENT DRUG SAFETY (2006)
Next-day residual effects of hypnotics in DSM-IV primary insomnia:: a driving simulator study with simultaneous electroencephalogram monitoring
L Staner et al.
PSYCHOPHARMACOLOGY (2005)
Eszopiclone for insomnia
ST Melton et al.
ANNALS OF PHARMACOTHERAPY (2005)
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia
M Scharf et al.
SLEEP (2005)
The influence of age and sex on the clearance of cytochrome P450 3A substrates
MM Cotreau et al.
CLINICAL PHARMACOKINETICS (2005)
An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults
R Rosenberg et al.
SLEEP MEDICINE (2005)
Residual effects of sleep medication on driving ability
JC Verster et al.
SLEEP MEDICINE REVIEWS (2004)
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia
GK Zammit et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Escitalopram versus citalopram:: the surprising role of the R-enantiomer
C Sánchez et al.
PSYCHOPHARMACOLOGY (2004)
Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate
DJ Greenblatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Single-enantiomer drugs - Elegant science, disappointing effects
P Mansfield et al.
CLINICAL PHARMACOKINETICS (2004)
Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives - Zaleplon, zolpidem and zopiclone
DR Drover
CLINICAL PHARMACOKINETICS (2004)
Residual effects of hypnotics - Epidemiology and clinical implications
A Vermeeren
CNS DRUGS (2004)
Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects.: A randomized, cross-over, double-blind study versus placebo
H Allain et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia
AD Krystal et al.
SLEEP (2003)
Clinically important drug interactions with zopiclone, zolpidem and zaleplon
LM Hesse et al.
CNS DRUGS (2003)
Putting chirality to work: The strategy of chiral switches
I Agranat et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite
JN Carlson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation
H Yin et al.
XENOBIOTICA (2000)
Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
K Venkatakrishnan et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
